Quantitative Assessment of Minimal Residual Disease in Acute Myeloid Leukemia Carrying Nucleophosmin (NPM1) Gene Mutations

Leukemia - United Kingdom
doi 10.1038/sj.leu.2404149
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2007English

Nucleophosmin Mutations in Acute Myeloid Leukemia in Children

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Acute Myeloid Leukemia With NPM1 Somatic Mutations

2020English

Rapid Method for Detection of Mutations in the Nucleophosmin Gene in Acute Myeloid Leukemia

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2008English

Nucleophosmin (NPM1) Mutations in Acute Myeloid Leukemia: An Ongoing (Cytoplasmic) Tale of Dueling Mutations and Duality of Molecular Genetic Testing Methodologies

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2008English

Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?

Journal of Clinical Medicine
2017English

Rapid and Highly Specific Screening for NPM1 Mutations in Acute Myeloid Leukemia

Annals of Hematology
MedicineHematology
2012English

Molecular Minimal Residual Disease Negativity and Decreased Stem Cell Mobilization Potential Predict Excellent Outcome After Autologous Transplant in NPM1 Mutant Acute Myeloid Leukemia.

Haematologica
Hematology
2019English

Genetic Mutation Assessment of NPM1 Gene and Gene Expression of MDR1 in Iraqi Patients With Acute Myeloid Leukemia

OnLine Journal of Biological Sciences
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy